{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T11:27:02Z","timestamp":1792582022647,"version":"4.5.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100014589","name":"Chief Scientist Office, Scottish Government Health and Social Care Directorate","doi-asserted-by":"publisher","award":["HIPS 19\/17"],"award-info":[{"award-number":["HIPS 19\/17"]}],"id":[{"id":"10.13039\/100014589","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Health Econ Health Policy"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s40258-025-00948-x","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T02:40:41Z","timestamp":1741920041000},"page":"425-439","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Beyond the Diagnosis: Valuing Genome-Wide Sequencing for Rare Disease Diagnosis Using Contingent Valuation"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3418-0666","authenticated-orcid":false,"given":"Michael","family":"Abbott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandy","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Heidenreich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zosia","family":"Miedzybrodzka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,14]]},"reference":[{"issue":"2","key":"948_CR1","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41431-019-0508-0","volume":"28","author":"S Nguengang Wakap","year":"2020","unstructured":"Nguengang Wakap S, et al. Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database. Eur J Hum Genet. 2020;28(2):165\u201373. https:\/\/doi.org\/10.1038\/s41431-019-0508-0.","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"948_CR2","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/s41431-022-01226-3","volume":"31","author":"LJ Hocking","year":"2023","unstructured":"Hocking LJ, et al. Genome sequencing with gene panel-based analysis for rare inherited conditions in a publicly funded healthcare system: implications for future testing. Eur J Hum Genet. 2023;31(2):231\u20138. https:\/\/doi.org\/10.1038\/s41431-022-01226-3.","journal-title":"Eur J Hum Genet"},{"issue":"11","key":"948_CR3","first-page":"1","volume":"20","author":"Ontario Health (Quality)","year":"2020","unstructured":"Ontario Health (Quality). Genome-wide sequencing for unexplained developmental disabilities or multiple congenital anomalies: a health technology assessment. Ont Health Technol Assess Ser. 2020;20(11):1\u2013178.","journal-title":"Ont Health Technol Assess Ser."},{"issue":"9975","key":"948_CR4","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/S0140-6736(14)61705-0","volume":"385","author":"CF Wright","year":"2015","unstructured":"Wright CF, et al. Genetic diagnosis of developmental disorders in the DDD study: a scalable analysis of genome-wide research data. Lancet. 2015;385(9975):1305\u201314. https:\/\/doi.org\/10.1016\/S0140-6736(14)61705-0.","journal-title":"Lancet"},{"issue":"10","key":"948_CR5","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1038\/s41431-021-00882-1","volume":"29","author":"S Pollard","year":"2021","unstructured":"Pollard S, et al. Toward the diagnosis of rare childhood genetic diseases: what do parents value most? Eur J Hum Genet. 2021;29(10):1491\u2013501. https:\/\/doi.org\/10.1038\/s41431-021-00882-1.","journal-title":"Eur J Hum Genet"},{"issue":"5","key":"948_CR6","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s12687-021-00541-4","volume":"13","author":"M Abbott","year":"2022","unstructured":"Abbott M, et al. Continuing the sequence? Towards an economic evaluation of whole genome sequencing for the diagnosis of rare diseases in Scotland. J Community Genet. 2022;13(5):487\u2013501. https:\/\/doi.org\/10.1007\/s12687-021-00541-4.","journal-title":"J Community Genet"},{"issue":"10\u201311","key":"948_CR7","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1177\/08830738221113901","volume":"37","author":"A Alam","year":"2022","unstructured":"Alam A, Parfyonov M, Huang CY, Gill I, Connolly MB, Illes J. Targeted whole exome sequencing in children with early-onset epilepsy: parent experiences. J Child Neurol. 2022;37(10\u201311):840\u201350. https:\/\/doi.org\/10.1177\/08830738221113901.","journal-title":"J Child Neurol"},{"issue":"1","key":"948_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/jgc4.1894","volume":"34","author":"B Stafford-Smith","year":"2025","unstructured":"Stafford-Smith B, Sullivan JA, McAllister M, Walley N, Shashi V, McConkie-Rosell A. \u2018The book is just being written: the enduring journey of parents of children with emerging- ultrarare disorders. J Genet Couns. 2025;34(1): e1894. https:\/\/doi.org\/10.1002\/jgc4.1894.","journal-title":"J Genet Couns"},{"issue":"6","key":"948_CR9","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1038\/s41436-021-01110-3","volume":"23","author":"H Copeland","year":"2021","unstructured":"Copeland H, Kivuva E, Firth HV, Wright CF. Systematic assessment of outcomes following a genetic diagnosis identified through a large-scale research study into developmental disorders. Genet Med. 2021;23(6):1058\u201364. https:\/\/doi.org\/10.1038\/s41436-021-01110-3.","journal-title":"Genet Med"},{"issue":"8","key":"948_CR10","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.3390\/jpm12081250","volume":"12","author":"J Martinussen","year":"2022","unstructured":"Martinussen J, Chalk M, Elliott J, Gallacher L. Receiving genomic sequencing results through the Victorian Undiagnosed Disease Program: exploring parental experiences. J Pers Med. 2022;12(8):1250. https:\/\/doi.org\/10.3390\/jpm12081250.","journal-title":"J Pers Med."},{"issue":"6","key":"948_CR11","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41431-023-01375-z","volume":"32","author":"I Slegers","year":"2024","unstructured":"Slegers I, et al. Searching for a sense of closure: parental experiences of recontacting after a terminated pregnancy for congenital malformations. Eur J Hum Genet. 2024;32(6):673\u201380. https:\/\/doi.org\/10.1038\/s41431-023-01375-z.","journal-title":"Eur J Hum Genet"},{"issue":"20","key":"948_CR12","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1056\/NEJMoa2035790","volume":"385","author":"The 100,000 Genomes Project Pilot Investigators","year":"2021","unstructured":"The 100,000 Genomes Project Pilot Investigators. 100,000 Genomes Pilot on rare-disease diagnosis in health care: preliminary report. N Engl J Med. 2021;385(20):1868\u201380. https:\/\/doi.org\/10.1056\/NEJMoa2035790.","journal-title":"N Engl J Med"},{"issue":"5","key":"948_CR13","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S0277-9536(96)00215-8","volume":"44","author":"C Donaldson","year":"1997","unstructured":"Donaldson C, Shackley P. \u2018Does \u201cprocess utility\u201d exist? A case study of willingness to pay for laparoscopic cholecystectomy. Soc Sci Med. 1997;44(5):699\u2013707. https:\/\/doi.org\/10.1016\/S0277-9536(96)00215-8.","journal-title":"Soc Sci Med"},{"issue":"1","key":"948_CR14","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/dmcn.14971","volume":"64","author":"SM Nevin","year":"2022","unstructured":"Nevin SM, et al. Psychosocial impact of genetic testing on parents of children with developmental and epileptic encephalopathy. Dev Med Child Neuro. 2022;64(1):95\u2013104. https:\/\/doi.org\/10.1111\/dmcn.14971.","journal-title":"Dev Med Child Neuro"},{"issue":"4","key":"948_CR15","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1002\/ajmg.a.62619","volume":"188","author":"MC Halley","year":"2022","unstructured":"Halley MC, et al. Perceived utility and disutility of genomic sequencing for pediatric patients: perspectives from parents with diverse sociodemographic characteristics. Am J Med Genet A. 2022;188(4):1088\u2013101. https:\/\/doi.org\/10.1002\/ajmg.a.62619.","journal-title":"Am J Med Genet A"},{"issue":"5","key":"948_CR16","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1002\/jgc4.1818","volume":"33","author":"J Gurasashvili","year":"2024","unstructured":"Gurasashvili J, Silverio SA, Hill M, Peter M, Stafford-Smith B, Lewis C. The disequilibrium of hope: a grounded theory analysis of parents\u2019 experiences of receiving a \u201cno primary finding\u201d result from genome sequencing. J Genet Couns. 2024;33(5):1089\u2013102. https:\/\/doi.org\/10.1002\/jgc4.1818.","journal-title":"J Genet Couns"},{"issue":"11","key":"948_CR17","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1038\/s41431-020-0667-z","volume":"28","author":"M Hill","year":"2020","unstructured":"Hill M, Hammond J, Lewis C, Mellis R, Clement E, Chitty LS. Delivering genome sequencing for rapid genetic diagnosis in critically ill children: parent and professional views, experiences and challenges. Eur J Hum Genet. 2020;28(11):1529\u201340. https:\/\/doi.org\/10.1038\/s41431-020-0667-z.","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"948_CR18","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/jgc4.1454","volume":"31","author":"NSY Liang","year":"2022","unstructured":"Liang NSY, et al. After genomic testing results: parents\u2019 long-term views. J Genet Couns. 2022;31(1):82\u201395. https:\/\/doi.org\/10.1002\/jgc4.1454.","journal-title":"J Genet Couns"},{"issue":"6","key":"948_CR19","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1002\/pd.6112","volume":"42","author":"AN Talati","year":"2022","unstructured":"Talati AN, Gilmore KL, Hardisty EE, Lyerly AD, Rini C, Vora NL. Parental motivations for and adaptation to trio-exome sequencing in a prospective prenatal testing cohort: beyond the diagnosis. Prenat Diagn. 2022;42(6):775\u201382. https:\/\/doi.org\/10.1002\/pd.6112.","journal-title":"Prenat Diagn"},{"issue":"9","key":"948_CR20","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/s41431-020-0640-x","volume":"28","author":"C Mighton","year":"2020","unstructured":"Mighton C, et al. Quality of life drives patients\u2019 preferences for secondary findings from genomic sequencing. Eur J Hum Genet. 2020;28(9):1178\u201386. https:\/\/doi.org\/10.1038\/s41431-020-0640-x.","journal-title":"Eur J Hum Genet"},{"issue":"8","key":"948_CR21","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1136\/medethics-2016-103564","volume":"43","author":"JA Anderson","year":"2017","unstructured":"Anderson JA, et al. Parents perspectives on whole genome sequencing for their children: qualified enthusiasm? J Med Ethics. 2017;43(8):535\u20139. https:\/\/doi.org\/10.1136\/medethics-2016-103564.","journal-title":"J Med Ethics"},{"issue":"11","key":"948_CR22","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1038\/s41431-024-01653-4","volume":"32","author":"M Droin-Mollard","year":"2024","unstructured":"Droin-Mollard M, et al. Psychological and ethical issues raised by genomic in paediatric care pathway, a qualitative analysis with parents and childhood cancer patients. Eur J Hum Genet. 2024;32(11):1446\u201355. https:\/\/doi.org\/10.1038\/s41431-024-01653-4.","journal-title":"Eur J Hum Genet"},{"issue":"6","key":"948_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2024.101103","volume":"26","author":"JJ Nolan","year":"2024","unstructured":"Nolan JJ, Forrest J, Ormondroyd E. Additional findings from the 100,000 Genomes Project: a qualitative study of recipient perspectives. Genet Med. 2024;26(6): 101103. https:\/\/doi.org\/10.1016\/j.gim.2024.101103.","journal-title":"Genet Med"},{"issue":"22","key":"948_CR24","doi-asserted-by":"publisher","first-page":"3620","DOI":"10.1002\/cncr.34917","volume":"129","author":"BC McGill","year":"2023","unstructured":"McGill BC, et al. Parents\u2019 expectations, preferences, and recall of germline findings in a childhood cancer precision medicine trial. Cancer. 2023;129(22):3620\u201332. https:\/\/doi.org\/10.1002\/cncr.34917.","journal-title":"Cancer"},{"issue":"2","key":"948_CR25","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/jgc4.1075","volume":"28","author":"S Makhnoon","year":"2019","unstructured":"Makhnoon S, Shirts BH, Bowen DJ. Patients\u2019 perspectives of variants of uncertain significance and strategies for uncertainty management. J Genet Couns. 2019;28(2):313\u201325. https:\/\/doi.org\/10.1002\/jgc4.1075.","journal-title":"J Genet Couns"},{"issue":"6","key":"948_CR26","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/ejhg.2017.10","volume":"25","author":"JN Kohler","year":"2017","unstructured":"Kohler JN, Turbitt E, Biesecker BB. Personal utility in genomic testing: a systematic literature review. Eur J Hum Genet. 2017;25(6):662\u20138. https:\/\/doi.org\/10.1038\/ejhg.2017.10.","journal-title":"Eur J Hum Genet"},{"issue":"3","key":"948_CR27","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s40271-021-00558-4","volume":"15","author":"HS Smith","year":"2022","unstructured":"Smith HS, et al. Perceived utility of genomic sequencing: qualitative analysis and synthesis of a conceptual model to inform patient-centered instrument development. Patient. 2022;15(3):317\u201328. https:\/\/doi.org\/10.1007\/s40271-021-00558-4.","journal-title":"Patient"},{"issue":"6","key":"948_CR28","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s40273-015-0261-3","volume":"33","author":"J Buchanan","year":"2015","unstructured":"Buchanan J, Wordsworth S. Welfarism versus extra-welfarism: can the choice of economic evaluation approach impact on the adoption decisions recommended by economic evaluation studies? Pharmacoeconomics. 2015;33(6):571\u20139. https:\/\/doi.org\/10.1007\/s40273-015-0261-3.","journal-title":"Pharmacoeconomics"},{"issue":"3","key":"948_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0229923","volume":"15","author":"A-L Byrne","year":"2020","unstructured":"Byrne A-L, Baldwin A, Harvey C. Whose centre is it anyway? Defining person-centred care in nursing: an integrative review. PLoS ONE. 2020;15(3): e0229923. https:\/\/doi.org\/10.1371\/journal.pone.0229923.","journal-title":"PLoS ONE"},{"key":"948_CR30","unstructured":"Scottish Government. Genomics in Scotland: building or future. Delivering an equitable, person-centred, population-based genomic medicine service for Scotland: a five-year national strategy. 2024. https:\/\/www.gov.scot\/publications\/scotlands-genomic-medicine-strategy-2024-2029\/documents\/. Accessed 29 Jan 2025."},{"issue":"1","key":"948_CR31","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12955-023-02216-9","volume":"21","author":"T Pan","year":"2023","unstructured":"Pan T, Wu Y, Buchanan J, Goranitis I. QALYs and rare diseases: exploring the responsiveness of SF-6D, EQ-5D-5L and AQoL-8D following genomic testing for childhood and adult-onset rare genetic conditions in Australia. Health Qual Life Outcomes. 2023;21(1):132. https:\/\/doi.org\/10.1186\/s12955-023-02216-9.","journal-title":"Health Qual Life Outcomes"},{"issue":"3","key":"948_CR32","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/hec.2795","volume":"22","author":"K Payne","year":"2013","unstructured":"Payne K, McAllister M, Davies LM. Valuing the economic benefits of complex interventions: when maximising health is not sufficient. Health Econ. 2013;22(3):258\u201371. https:\/\/doi.org\/10.1002\/hec.2795.","journal-title":"Health Econ"},{"issue":"12","key":"948_CR33","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/j.jval.2024.07.008","volume":"27","author":"AC Klimchak","year":"2024","unstructured":"Klimchak AC, Sedita LE, Perfetto EM, Gooch KL, Malone DC. Discriminatory properties of quality-adjusted life year based cost-effectiveness analyses for patients with disabilities: a Duchenne muscular dystrophy case study. Value Health. 2024;27(12):1641\u20137. https:\/\/doi.org\/10.1016\/j.jval.2024.07.008.","journal-title":"Value Health."},{"issue":"5","key":"948_CR34","doi-asserted-by":"publisher","first-page":"qzae053","DOI":"10.1093\/haschl\/qxae053","volume":"2","author":"DA Marshall","year":"2024","unstructured":"Marshall DA, et al. Paving the path for implementation of clinical genomic sequencing globally: are we ready? Health Aff Sch. 2024;2(5):qzae053. https:\/\/doi.org\/10.1093\/haschl\/qxae053.","journal-title":"Health Aff Sch."},{"issue":"4","key":"948_CR35","first-page":"213","volume":"2","author":"JFP Bridges","year":"2003","unstructured":"Bridges JFP. Stated preference methods in health care evaluation: an emerging methodological paradigm in health economics. Appl Health Econ Health Policy. 2003;2(4):213\u201324.","journal-title":"Appl Health Econ Health Policy"},{"issue":"2","key":"948_CR36","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/hec.1697","volume":"21","author":"EW De Bekker-Grob","year":"2012","unstructured":"De Bekker-Grob EW, Ryan M, Gerard K. Discrete choice experiments in health economics: a review of the literature. Health Econ. 2012;21(2):145\u201372. https:\/\/doi.org\/10.1002\/hec.1697.","journal-title":"Health Econ"},{"key":"948_CR37","doi-asserted-by":"publisher","DOI":"10.4337\/9780857938138.00056","volume-title":"The Elgar companion to health economics","author":"C Donaldson","year":"2012","unstructured":"Donaldson C, Mason H, Shackley P. Contingent valuation in health care. In: Jones AM, editor. The Elgar companion to health economics. 2nd ed. Cheltenham: Edward Elgar Publishing; 2012. https:\/\/doi.org\/10.4337\/9780857938138.00056.","edition":"2"},{"issue":"4","key":"948_CR38","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/j.1365-2753.2005.00539.x","volume":"11","author":"M Ryan","year":"2005","unstructured":"Ryan M, Major K, Sk\u00e5tun D. Using discrete choice experiments to go beyond clinical outcomes when evaluating clinical practice. Eval Clin Pract. 2005;11(4):328\u201338. https:\/\/doi.org\/10.1111\/j.1365-2753.2005.00539.x.","journal-title":"Eval Clin Pract"},{"issue":"2","key":"948_CR39","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s40273-021-01103-9","volume":"40","author":"Y Meng","year":"2022","unstructured":"Meng Y, Clarke PM, Goranitis I. The value of genomic testing: a contingent valuation across six child- and adult-onset genetic conditions. Pharmacoeconomics. 2022;40(2):215\u201323. https:\/\/doi.org\/10.1007\/s40273-021-01103-9.","journal-title":"Pharmacoeconomics"},{"key":"948_CR40","unstructured":"Scottish Genomes Partnership. Rare disease collaboration with the Genomics England 100,000 Genomes Project. Available from: https:\/\/www.scottishgenomespartnership.org\/sgp-100-000-genomes-project. [Accessed 29 Jan 2025]."},{"issue":"8","key":"948_CR41","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1111\/j.1469-8749.2011.04032.x","volume":"53","author":"HV Firth","year":"2011","unstructured":"Firth HV, Wright CF, DDD Study. The deciphering developmental disorders (DDD) study. Dev Med Child Neurol. 2011;53(8):702\u20133. https:\/\/doi.org\/10.1111\/j.1469-8749.2011.04032.x.","journal-title":"Dev Med Child Neurol"},{"issue":"3","key":"948_CR42","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/hec.1369","volume":"18","author":"M Ryan","year":"2009","unstructured":"Ryan M, Watson V, Entwistle V. Rationalising the \u201cirrational\u201d: a think aloud study of discrete choice experiment responses. Health Econ. 2009;18(3):321\u201336. https:\/\/doi.org\/10.1002\/hec.1369.","journal-title":"Health Econ"},{"issue":"3","key":"948_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2022.12.003","volume":"25","author":"E Turbitt","year":"2023","unstructured":"Turbitt E, et al. The PrU: development and validation of a measure to assess personal utility of genomic results. Genet Med. 2023;25(3): 100356. https:\/\/doi.org\/10.1016\/j.gim.2022.12.003.","journal-title":"Genet Med"},{"issue":"2","key":"948_CR44","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s10897-018-0286-9","volume":"28","author":"M Li","year":"2019","unstructured":"Li M, et al. The feelings about genomic testing results (FACToR) Questionnaire: development and preliminary validation. J Genet Couns. 2019;28(2):477\u201390. https:\/\/doi.org\/10.1007\/s10897-018-0286-9.","journal-title":"J Genet Couns"},{"issue":"4","key":"948_CR45","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1257\/jep.8.4.19","volume":"8","author":"WM Hanemann","year":"1994","unstructured":"Hanemann WM. Valuing the environment through contingent valuation. J Econ Perspect. 1994;8(4):19\u201343. https:\/\/doi.org\/10.1257\/jep.8.4.19.","journal-title":"J Econ Perspect"},{"issue":"1","key":"948_CR46","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/0167-6296(90)90043-3","volume":"9","author":"C Donaldson","year":"1990","unstructured":"Donaldson C. Willingness to pay for publicly-provided goods. J Health Econ. 1990;9(1):103\u201318. https:\/\/doi.org\/10.1016\/0167-6296(90)90043-3.","journal-title":"J Health Econ"},{"issue":"3","key":"948_CR47","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1046\/j.1369-6513.2001.00126.x","volume":"4","author":"C Donaldson","year":"2001","unstructured":"Donaldson C. Eliciting patients\u2019 values by use of \u201cwillingness to pay\u201d: letting the theory drive the method. Health Expect. 2001;4(3):180\u20138. https:\/\/doi.org\/10.1046\/j.1369-6513.2001.00126.x.","journal-title":"Health Expect"},{"issue":"1","key":"948_CR48","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1046\/j.1523-536x.1998.00032.x","volume":"25","author":"C Donaldson","year":"1998","unstructured":"Donaldson C, Hundley V, Mapp T. Willingness to pay: a method for measuring preferences for maternity care? Birth. 1998;25(1):32\u20139. https:\/\/doi.org\/10.1046\/j.1523-536x.1998.00032.x.","journal-title":"Birth"},{"issue":"1","key":"948_CR49","doi-asserted-by":"publisher","first-page":"20","DOI":"10.2307\/1241972","volume":"70","author":"KJ Boyle","year":"1988","unstructured":"Boyle KJ, Bishop RC. Welfare measurements using contingent valuation: a comparison of techniques. Am J Agri Econ. 1988;70(1):20\u20138. https:\/\/doi.org\/10.2307\/1241972.","journal-title":"Am J Agri Econ."},{"issue":"1","key":"948_CR50","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1080\/000368497327425","volume":"29","author":"C Donaldson","year":"1997","unstructured":"Donaldson C, Thomas R, Torgerson DJ. Validity of open-ended and payment scale approaches to eliciting willingness to pay. Appl Econ. 1997;29(1):79\u201384. https:\/\/doi.org\/10.1080\/000368497327425.","journal-title":"Appl Econ"},{"key":"948_CR51","unstructured":"Arrow K, Solow R, Portney P, Leamer E, Radner R, Schuman H. Report of the NOAA Panel on Contingent Valuation. Fed Regist. 1993;58 (10):4601\u20134."},{"issue":"6","key":"948_CR52","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1177\/0272989X17691771","volume":"37","author":"M Pennington","year":"2017","unstructured":"Pennington M, Gomes M, Donaldson C. Handling protest responses in contingent valuation surveys. Med Decis Mak. 2017;37(6):623\u201334. https:\/\/doi.org\/10.1177\/0272989X17691771.","journal-title":"Med Decis Mak"},{"issue":"4","key":"948_CR53","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.ecolecon.2005.04.021","volume":"57","author":"J Meyerhoff","year":"2006","unstructured":"Meyerhoff J, Liebe U. Protest beliefs in contingent valuation: explaining their motivation. Ecol Econ. 2006;57(4):583\u201394. https:\/\/doi.org\/10.1016\/j.ecolecon.2005.04.021.","journal-title":"Ecol Econ"},{"issue":"5","key":"948_CR54","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1080\/000368498325651","volume":"30","author":"C Donaldson","year":"1998","unstructured":"Donaldson C, Jones AM, Mapp TJ, Olson JA. Limited dependent variables in willingness to pay studies: applications in health care. Appl Econ. 1998;30(5):667\u201377. https:\/\/doi.org\/10.1080\/000368498325651.","journal-title":"Appl Econ"},{"issue":"2","key":"948_CR55","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3917\/rel.782.0053","volume":"78","author":"N Havet","year":"2012","unstructured":"Havet N, Morelle M, Remonnay R, Carr\u00e8re M-O. Econometric treatment of few protest responses in willingness-to-pay studies: an application in health care. Louvain Econ Rev. 2012;78(2):53\u201374. https:\/\/doi.org\/10.3917\/rel.782.0053.","journal-title":"Louvain Econ Rev."},{"issue":"7","key":"948_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0200139","volume":"13","author":"EV Clarke","year":"2018","unstructured":"Clarke EV, et al. Assessment of willingness to pay for expanded carrier screening among women and couples undergoing preconception carrier screening. PLoS ONE. 2018;13(7): e0200139. https:\/\/doi.org\/10.1371\/journal.pone.0200139.","journal-title":"PLoS ONE"},{"issue":"2","key":"948_CR57","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s40271-015-0133-0","volume":"9","author":"E Gray","year":"2016","unstructured":"Gray E, Eden M, Vass C, McAllister M, Louviere J, Payne K. Valuing preferences for the process and outcomes of clinical genetics services: a pilot study. Patient. 2016;9(2):135\u201347. https:\/\/doi.org\/10.1007\/s40271-015-0133-0.","journal-title":"Patient"},{"key":"948_CR58","doi-asserted-by":"publisher","first-page":"S345","DOI":"10.1016\/j.jval.2020.04.1311","volume":"23","author":"C Mansfield","year":"2020","unstructured":"Mansfield C, Boeri M, Coulter J, Baranowski E, Sparks S, Hamed A. Preferences for genetic tests: trading off speed of diagnosis, availability of treatment, and cost. Value Health. 2020;23:S345. https:\/\/doi.org\/10.1016\/j.jval.2020.04.1311.","journal-title":"Value Health."},{"issue":"11","key":"948_CR59","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1038\/s41431-021-00874-1","volume":"29","author":"I Goranitis","year":"2021","unstructured":"Goranitis I, Best S, Christodoulou J, Boughtwood T, Stark Z. Preferences and values for rapid genomic testing in critically ill infants and children: a discrete choice experiment. Eur J Hum Genet. 2021;29(11):1645\u201353. https:\/\/doi.org\/10.1038\/s41431-021-00874-1.","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"948_CR60","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1159\/000203780","volume":"12","author":"EA Geelhoed","year":"2009","unstructured":"Geelhoed EA, Harrison K, Davey A, Walpole IR. Parental perspective of the benefits of genetic testing in children with congenital deafness. Public Health Genom. 2009;12(4):245\u201350. https:\/\/doi.org\/10.1159\/000203780.","journal-title":"Public Health Genom"},{"issue":"1","key":"948_CR61","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41436-020-00949-2","volume":"23","author":"I Goranitis","year":"2021","unstructured":"Goranitis I, Best S, Stark Z, Boughtwood T, Christodoulou J. The value of genomic sequencing in complex pediatric neurological disorders: a discrete choice experiment. Genet Med. 2021;23(1):155\u201362. https:\/\/doi.org\/10.1038\/s41436-020-00949-2.","journal-title":"Genet Med"},{"issue":"8","key":"948_CR62","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27762","volume":"66","author":"BC McGill","year":"2019","unstructured":"McGill BC, et al. \u201cI remember how I felt, but I don\u2019t remember the gene\u201d: families\u2019 experiences of cancer-related genetic testing in childhood. Pediatr Blood Cancer. 2019;66(8): e27762. https:\/\/doi.org\/10.1002\/pbc.27762.","journal-title":"Pediatr Blood Cancer"},{"key":"948_CR63","doi-asserted-by":"publisher","unstructured":"Aldridge CE, Osiovich H, Siden H (Hal); RAPIDOMICS Study, GenCOUNSEL Study; Elliott AM. Rapid genome\u2010wide sequencing in a neonatal intensive care unit: a retrospective qualitative exploration of parental experiences. J Genet Couns. 2021;30(2):616\u201329. https:\/\/doi.org\/10.1002\/jgc4.1353.","DOI":"10.1002\/jgc4.1353"},{"issue":"3","key":"948_CR64","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1007\/s10897-016-0032-0","volume":"26","author":"K Haude","year":"2017","unstructured":"Haude K, McCarthy Veach P, LeRoy B, Zierhut H. Factors influencing the decision-making process and long-term interpersonal outcomes for parents who undergo preimplantation genetic diagnosis for Fanconi anemia: a aqualitative investigation. J Genet Couns. 2017;26(3):640\u201355. https:\/\/doi.org\/10.1007\/s10897-016-0032-0.","journal-title":"J Genet Couns"},{"issue":"5","key":"948_CR65","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/s41431-022-01065-2","volume":"30","author":"M Peter","year":"2022","unstructured":"Peter M, et al. Participant experiences of genome sequencing for rare diseases in the 100,000 Genomes Project: a mixed methods study. Eur J Hum Genet. 2022;30(5):604\u201310. https:\/\/doi.org\/10.1038\/s41431-022-01065-2.","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"948_CR66","doi-asserted-by":"publisher","DOI":"10.1002\/jgc4.1904","volume":"34","author":"J Howard","year":"2024","unstructured":"Howard J, Forrest Keenan K, Mazanderani F, Turner MR, Locock L. Experiences of predictive genetic testing in inherited motor neuron disease: findings from a qualitative interview study. J Genet Couns. 2024;34(1): e1904. https:\/\/doi.org\/10.1002\/jgc4.1904.","journal-title":"J Genet Couns"},{"issue":"8","key":"948_CR67","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1136\/bjophthalmol-2012-303020","volume":"97","author":"M Eden","year":"2013","unstructured":"Eden M, Payne K, Combs RM, Hall G, McAllister M, Black GCM. Valuing the benefits of genetic testing for retinitis pigmentosa: a pilot application of the contingent valuation method. Br J Ophthalmol. 2013;97(8):1051\u20136. https:\/\/doi.org\/10.1136\/bjophthalmol-2012-303020.","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"948_CR68","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/gim.2018.16","volume":"20","author":"NA Kasparian","year":"2018","unstructured":"Kasparian NA, De Abreu LR, Winlaw DS, Sholler GF, Viney R, Kirk EPE. Tell me once, tell me soon: parents\u2019 preferences for clinical genetics services for congenital heart disease. Genet Med. 2018;20(11):1387\u201395. https:\/\/doi.org\/10.1038\/gim.2018.16.","journal-title":"Genet Med"},{"issue":"10","key":"948_CR69","doi-asserted-by":"publisher","first-page":"103711","DOI":"10.1016\/j.ejmg.2019.103711","volume":"62","author":"F Houdayer","year":"2019","unstructured":"Houdayer F, et al. Secondary findings from next generation sequencing: psychological and ethical issues. Family and patient perspectives. Eur J Med Genet. 2019;62(10):103711. https:\/\/doi.org\/10.1016\/j.ejmg.2019.103711.","journal-title":"Eur J Med Genet"},{"issue":"1","key":"948_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2023.100994","volume":"26","author":"E Turbitt","year":"2024","unstructured":"Turbitt E, et al. The parent PrU: a measure to assess personal utility of pediatric genomic results. Genet Med. 2024;26(1): 100994. https:\/\/doi.org\/10.1016\/j.gim.2023.100994.","journal-title":"Genet Med"}],"container-title":["Applied Health Economics and Health Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40258-025-00948-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40258-025-00948-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40258-025-00948-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T13:36:08Z","timestamp":1746452168000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40258-025-00948-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,14]]},"references-count":70,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["948"],"URL":"https:\/\/doi.org\/10.1007\/s40258-025-00948-x","relation":{},"ISSN":["1175-5652","1179-1896"],"issn-type":[{"value":"1175-5652","type":"print"},{"value":"1179-1896","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,14]]},"assertion":[{"value":"19 January 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was funded by the Chief Scientist Office for Scotland, Grant Reference: HIPS 19\/17.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Michael Abbott, Mandy Ryan, Rodolfo Hern\u00e1ndez, Sebastian Heidenreich and Zosia Miedzybrodzka have no conflicts of interest that are directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"Approval for the study was granted by North of Scotland Research Committee 1 (IRAS ID 289518).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Study participants provided electronic informed consent for participation in the survey.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Study participants provided electronic informed consent for the publication of results.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"De-identified data and study materials are available from the corresponding author upon reasonable request.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"The code is available upon reasonable request to the corresponding author.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"MR, ZM, RH and SH conceived the study and acquired funding. All authors developed the contingent valuation survey; MA administered the survey and collected data. MA, RH and SH analysed the data. MA wrote the original draft manuscript. All authors critically reviewed, edited and approved the final manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 Contributions"}}]}}